Company intelligence / Profile preview

FERREMUNDO

Ownership: Private
Development stage: Commercial

Overview

FERREMUNDO S.A. is listed as a distributor or importer for real-time RT-PCR COVID-19 diagnostic kits approved during the pandemic in Ecuador; no clinical trial results are relevant as it is not a drug developer.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic test
Industry: Molecular Diagnostics

Partnerships

MYPOLS BIOTECH GMBH (Germany; supplier/manufacturer of PCR kits distributed by FERREMUNDO S.A.[6])

Beyond the preview

Go deeper on FERREMUNDO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FERREMUNDO.

Explore the full profile